Resources and Links

General Resources

For general product information including how to order CYANOKIT^® or other Meridian Medical Technologies^®, Inc. products, please contact us via email at customerservice@meridianmt.com, visit MeridianMeds.com, or call 1-800-638-8093
If you would like medical information about CYANOKIT^® or other Meridian Medical Technologies^®, Inc. products, please contact Professional Information Services in the United States at 1-800-776-3637

General Links

Cyanide Poisoning Treatment Coalition (CPTC) www.cyanidepoisoning.org
International Association of Fire Chiefs (IAFC) www.iafc.org
The National Association of EMS Educators (NAEMSE) www.naemse.org
National Fire Protection Association (NFPA) www.nfpa.org
Research Triangle Institute (RTI) www.rti.org
US Fire Administration (USFA) www.usfa.dhs.gov
Department of Homeland Security (DHS) www.dhs.gov
International Cyanide Management Institute (ICMI) www.CyanideCode.org

Grant Request Information

CYANOKIT^® Antidote is approved on the Department of Homeland Securities Authorized Equipment List (AEL), making it eligible for the following grant programs⁴²:

The State Homeland Security Program (SHSP)
Urban Area Security Initiative (UASI)
Metropolitan Medical Response System (MMRS)
Transit Security Grant Program (TSGP)

Join our mailing list to receive product updates and information on special events and promotions.

Indication
CYANOKIT^® Antidote is indicated for the treatment of known or suspected cyanide poisoning. If clinical suspicion of cyanide poisoning is high, CYANOKIT^® Antidote should be administered without delay.

Important Safety Information
Prior to administration of CYANOKIT^® Antidote, smoke-inhalation victims should be assessed for: exposure to fire or smoke in an enclosed area; presence of soot around the mouth, nose or oropharynx; altered mental status. Use caution in the management of patients with known anaphylactic reactions to hydroxocobalamin or cyanocobalamin. Allergic reactions may include: anaphylaxis, chest tightness, edema, urticaria, pruritus, dyspnea, and rash. Most common adverse reactions (>5%) are transient and include chromaturia (red-colored urine), erythema (skin redness), rash, increased blood pressure, nausea, headache, decreased lymphocyte percent, and injection site reactions. Usage may interfere with some clinical laboratory evaluations. If the decision is made to administer another antidote with CYANOKIT^®, these drugs should not be administered in the same IV line. The safety of simultaneous administration has not been established.

DISCLAIMER
The content of this Web site is not and should not be construed as medical advice. The content contained herein only constitutes commentary and is for educational and information purposes only. Reading this Web site, or any other interaction on this site, does not create a relationship between you and the Web site or its registered owner. As with any medical issue that may confront you in a particular situation, you should always consult a qualified healthcare professional.

This Web site is intended for United States of America (U.S.A.) residents only and is subject to all applicable U.S.A. laws. CYANOKIT^® Antidote is a registered trademark of Merck Santé s.a.s., licensed by Meridian Medical Technologies^®,Inc., a wholly owned subsidiary of King Pharmaceuticals^®, Inc. Copyright © 2009 Meridian Medical Technologies^®, Inc., a wholly owned subsidiary of King Pharmaceuticals^®, Inc. All rights reserved. MMT6577 10/2009

The expert advice of a regional poison control center may be obtained by calling 1-800-222-1222.